Next Article in Journal
Alpharetroviral Vectors: From a Cancer-Causing Agent to a Useful Tool for Human Gene Therapy
Next Article in Special Issue
KSHV LANA—The Master Regulator of KSHV Latency
Previous Article in Journal
Nomenclature- and Database-Compatible Names for the Two Ebola Virus Variants that Emerged in Guinea and the Democratic Republic of the Congo in 2014
Previous Article in Special Issue
KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
Article Menu

Export Article

Viruses 2014, 6(12), 4800-4810; doi:10.3390/v6124800

Article
Genotypic Analysis of Kaposi’s Sarcoma-Associated Herpesvirus from Patients with Kaposi’s Sarcoma in Xinjiang, China
1
State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China
2
Laboratory of Xinjiang Endemic and Ethnic Diseases, Shihezi University, Shihezi 832002, China
3
Department of Microbiology, Anhui Medical University, Hefei 230032, China
4
Central Laboratory of Molecular and Cellular Biology, School of Basic Medicine, Anhui Medical University, Hefei, Anhui 230032, China
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
External Editor: Zhi-Ming Zheng
Received: 27 September 2014; in revised form: 9 November 2014 / Accepted: 17 November 2014 / Published: 26 November 2014

Abstract

: Kaposi’s sarcoma-associated herpesvirus (KSHV) is the causal agent of all forms of Kaposi’s sarcoma (KS), including AIDS-KS, endemic KS, classic KS and iatrogenic KS. Based on Open reading frame (ORF) K1 sequence analysis, KSHV has been classified into seven major molecular subtypes (A, B, C, D, E, F and Z). The distribution of KSHV strains varies according to geography and ethnicity. Xinjiang is a unique region where the seroprevalence of KSHV is significantly higher than other parts of China. The genotyping of KSHV strains in this region has not been thoroughly studied. The present study aimed to evaluate the frequency of KSHV genotypes isolated from KS tissues in Classical KS and AIDS KS patients from Xinjiang, China. ORF-K1 of KSHV from tissue samples of 28 KS patients was amplified and sequenced. Two subtypes of KSHV were identified according to K1 genotyping. Twenty-three of them belonged to subtype A, while five of them were subtype C. More genotype A than genotype C strains were found in both Classical KS and AIDS KS. No significant difference was found in the prevalence of different genotype between Classical KS and AIDS KS.
Keywords:
Kaposi’s sarcoma-associated herpesvirus (KSHV); genotyping; K1 gene; Xinjiang

1. Introduction

Kaposi’s sarcoma (KS) is a tumor, originally described by Moritz Kaposi in 1872 [1] and became more widely known as one of the AIDS defining illness in the 1980s [2]. The clincoepidemiologic forms of KS have been classified as AIDS-KS, classic KS, endemic KS and iatrogenic KS [3]. Classic KS was an indolent cutaneous disease entity primarily involving the lower extremities, affecting elderly men especially from the Mediterranean region or of Eastern European decent [4,5]. In contrast, AIDS-associated KS is clinically more aggressive and can occur in all organs with the exception of the central nervous system; it stimulated the greatest interest as one of the first illness associated with AIDS [6,7].

Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is a gamma-2-herpesvirus or rhadinovirus. KSHV was first identified in a biopsy tissue from a patient with AIDS-related Kaposi’s sarcoma (AIDS-KS) by representational difference analysis in 1994 by Chang et al. [8]. KSHV is the causal agent of all forms of Kaposi’s sarcoma, including AIDS-KS, endemic KS and iatrogenic KS (in transplant recipients receiving immunosuppressive therapy) [8]. KSHV is also associated with two other lymphoproliferative malignancies, including primarily effusion lymphoma and multicentric Castleman’s disease (MCD) [9,10].

As a large double-stranded DNA virus, KSHV has approximately 90 identified open reading frames, of which over 60 show homology with other rhadinoviruses and 15, designated K1–K15, were unique to KSHV when its genome was first sequenced [11]. ORF-K1, at the left end of KSHV genome, encodes an early lytic transmembrane glycoprotein of 289 amino acids (aa). The amino acid sequence of K1 varies from 0.4% to 44% between different KSHV isolates, with the variations concentrated in two hyper-variable regions, VR1 and VR2. Current genotyping method of KSHV is based primarily on the sequence variations of the ORF-K1 gene. Based on K1 sequence analysis, KSHV has been classified into seven major molecular subtypes (A, B, C, D, E, F and Z) [12,13,14,15,16,17]. The distribution of KSHV strains varies according to geography and ethnicity, which appears to be attributable to human migrations. Subtype A and C are found in Europe, the USA, Middle East and Northern Asia; Subtype B is characteristic for Africa; Subtype D was found in individuals from the pacific Islands; Subtype E was found in Brazilian Amerindians; Subtype Z has been found in a small cohort of Zambian children; A new subtype F has been recently identified in Uganda.

Xinjiang Uygur Autonomous region is the largest province in northwestern China, and located on the ancient Silk Road as an important staging post over a thousand years ago. Xinjiang borders on Russia, Kazakhstan, Kyrgyzstan, Tajikistan, Pakistan, Mongolia, India and Afghanistan. Ethnic groups in Xinjiang are diverse and distinct, the main ethnic groups are the Uygur (45.7%) and the Han (39.7%), other ethnic minorities include Kazakh, Mongolians, Hui, Kirgiz, Manchu, and Xibo. Classic KS are rarely seen in the Han Chinese, but are seen more frequently in the Uygur ethnic group, more than one patient has been diagnosed histopathologically as having KS every year at the Affiliated Tumor Hospital of Xinjiang Medical University in Urumqi, the capital city of Xinjiang Uygur Autonomous Region. We have previously shown that the overall seroprevalence of KSHV was 19.2% in the general population in Xinjiang, which was substantially higher than the 9.5% seroprevalence of KSHV in the control subjects from the general population in Han Chinese in Hubei Province [18]. Our data indicated that Xinjiang is a unique region where the seroprevalence of KSHV is significantly higher than other parts of China. This high seroprevalence of KSHV is consistent with the high incidence of KS in this region.

Dilnur et al. (2001) had reported that KSHV strains from seven patients with classical KS in Xinjiang were classified as subtype C [19]. Zhang reported that, on the basis of the K1/VR1 amino acid sequence, that the majority of these KS patients were infected by subtype C (n = 18), and several by subtype A (n = 4) [20]. In this study, we collected 28 samples of KS patients in Xinjiang and examined the infection of KSHV by nested PCR and characterized the ORF-K1 genotypes.

2. Materials and Methods

2.1. Tissue Specimens

Twenty-eight KS classical tissue examples were collected from Xinjiang Uygur Autonomous Region, China. Seven of them were peripheral blood mononuclear cells examples and the rest were formalin-fixed paraffin-embedded tissues (FFPET). All the specimens were collected between 1997 and 2009. Eighteen of them were from Uygur patients, eight of them were from Kazakh Patients, one from a Hui patient and one from a Han patient. Permission to conduct the study and informed consent was obtained in accordance with a protocol approved by the Ethics Committee of Wuhan Institute of Virology, Chinese Academy of Sciences.

2.2. Preparation of DNA

DNA from peripheral blood mononuclear cells of KS patients was extracted with a Blood & Cell Culture DNA Mini Kit according to manufacturer’s instructions (Qiagen, Valencia, CA, USA).

DNA from FFPET was extracted as the following steps. Tissues were incubated at 55 °C with 1 mL xylene for 10 min, and then centrifuged at 8000 rpm for 5 min, supernatant was collected. The supernatant was further centrifuged at 8000 rpm for 5 min to totally remove the paraffin. The remaining dimethylbenzene was removed by using anhydrous ethanol. Then the supernatant was added with 250 μL cell lysis buffer (0.02 M Tris-HCl pH 8.0, 0.01 M EDTA pH 8.0, 2% SDS and 50 μL proteinase K (20 mg/mL) and kept at 55 °C over night. Equal volumes of phenol, chloroform, and isoamyl alcohol (25:24:1) were added to the supernatant. The supernatant was clarified by centrifugation at 8000 rpm for 2 min at 4 °C. Then 2.5 times the volume of pre-cold anhydrous alcohol was added to precipitate DNA. 30 min later, the mixture was centrifuged at 13,000 rpm for 10 min at 4 °C. The supernatant was discarded. After slightly drying, 20 μL TE (pH8.0) was added to dissolve DNA, and kept in −20 °C.

2.3. PCR Amplification

Fragments (363 bp) of the VR1 region of KSHV ORF-K1 were amplified by nested-PCR. Primers were designed as described [16]. Briefly, the forward and reverse primers for first round of PCR were 5’-GACCTTGTTGGACATCCTGTA-3’ and 5’-GAGTTTCTGGAGTTATATTG-3’. Primers for the second round of PCR were 5’-TTGTGCCCTGGAGTGATT-3’ and 5’-CAGCGTAAAATTATAGTA-3’. The PCR program was set as 35 cycles 95 °C for 1 min, 53 °C for 45 s, and 72 °C for 1 min in the first reaction; and 94 °C for 1 min, 48 °C for 45 s, and 72 °C for 1 min in the second reaction. PCR products were evaluated in 1.5% agarose gel electrophoresis and stained with ethidium bromide. Afterward, the products were purified using a Gel Extraction Kit (Omega Bio-Tek, Winooski, VT, USA) according to instructions of manufacturer.

2.4. DNA Sequencing

The purified K1 gene fragments were cloned into pGEM-T vector for constructing recombinant plasmid pGEM-T-K1 and transformed into DH5α competent cells. Then, the recombinant plasmid was extracted from DH5α cells using TIANprep Mini Plasmid Kit (TIANGEN BIOTECH CO., LTD, Beijing, China) and sent for sequencing by Shanghai Majorbio Biotech Co., Ltd. (Shanghai, China)

2.5. Phylogenetic Tree Analysis

Twenty-eight of the unique sequences (GenBank Accession numbers: KM582680–KM582707) and 19 other KSHV strains obtained from GenBank were used to construct the phylogenetic tree and were analyzed with a DNAStar package and aligned with Clustal W in Bioedit (version 7.0.0). Phylogenetic trees were constructed by neighbor-joining analysis by Phylip (version 3.68) and MEGA (version 4.0.2), respectively. The statistical reliability of the NJ tree was evaluated using 1000 bootstrap samples. TreeView (version 1.6.6) was used to see the trees constructed by Phylip. The sequences of 19 other KSHV strains consisted of 1 strain of subtype A1 XJ-27 (FJ853386); 1 strain of subtype A2: Ema-7 (AF130305); 1 strain of subtype A3: IT-268 (GU097421), 1 strain of subtype A4: BCBL-B (AF133039),US114 (GU097431) ; 1 strain of subtype A5: KE229 (GU097433); 3 strains of subtype B: UG-65 (FJ884618), UG-85 (FJ884620), MP10 (AF387367); 2 strains of subtype C2: XJ-6 (FJ853368), XJ30 (FJ853388); 1 strain of subtype C3: XJ-20 (FJ853379), AF17170531; 2 strains of subtype D: TKS10 (AF133043), ZKS3 (AF133044), 2 strains of subtype E: Sio1 (AY329025), Tupi1 (AF220292); and 2 strains of subtype F: AF178810, FJ884616.

2.6. Statistical Analysis

All the information of cases was analyzed by descriptive statistics. MS Excel was used to calculate the mean, standard deviation, coefficient of variation, and median of data. Fisher's exact test was used to test the associations of sex ratio and KSHV genotype between two groups and the associations of KS subtypes and KSHV subtypes. One-way analysis of variance (ANOVA) was used for statistical evaluation of differences between the two groups.

3. Results

3.1. KS Cases Characterization

Twenty-eight KS cases were evaluated for ORF-K1 genotype analysis. The number of male patients was higher than that of female patients. Male patients were 24/28 (85.71%), while female patients were 4/28 (14.29%). Classic KS cases were twenty-three, while AIDS-associated KS were five. Classic KS has a male/female ratio of 6.67 (20/3), and AIDS-associated KS has Male/Female Ratio of 4.0 (4/1). Compared to AIDS KS, the male/female ratio in Classic KS is higher but without significant difference by Fisher’s exact test. The mean ages for Classic KS and AIDS-KS were 54.39 and 23.80 years old, respectively. AIDS associated KS patients were younger than Classic KS (p < 0.001; ANOVA). (Table 1).

Table 1. Sex and age for KS patients studied.
Table 1. Sex and age for KS patients studied.
KS GroupsM/F RatioAge
Mean (Years)SD (Years)CV (%)P25P75Median (Years)Range (Years)
Classic KS (23)6.67 *54.3913.9425.6440.0065.5053.00 §32–73
AIDS-associated KS (5)4.00 *23.809.6540.5618.0029.0028.00 §10–34
Total (28)6.0048.9317.7436.2537.0063.0050.5010–73

M/F: male/female; SD: standard deviation; CV: coefficient of variation; P25: 25th percentile; P75: 75th percentile; * M/F ratios of two kind of KS has no significant difference (Fisher’s exact test); § p < 0.001 (ANOVA).

3.2. ORF-K1 Amplification

Total DNA were extracted from FFPET and plasmid samples. 363 bp of ORF-K1 VR1 region of KSHV were amplified by nested PCR from each sample. PCR products were detected by 1.5% agarose gel electrophoresis (see Supplementary File). DNA extracted from gel was cloned into pGEM-T vector, and then sent for sequencing.

3.3. Phylogenetic Analysis

The 363 bp K1 sequences of the 28 KSHV isolates from Xinjiang Uygur Autonomous Region, China were aligned with 19 previously reported sequences in the database of NCBI using Bioedit (version 7.0.0). Phylogenetic trees were constructed by neighbor-joining analysis by MEGA (version 4.0.2) and Phylip (version 3.68), respectively. From the MEGA phylogenetic trees (Figure 1), the Xinjiang cases were categorized into subtypes A and C. Twenty-three cases (82.14%) were categorized into subtype A and five cases (17.86%) categorized into subtype C in total. Of classic KS, 19 subjects (82.61%) were infected with subtype A and four subjects (13.91%) were infected with subtype C, while of AIDS-associated KS, four subjects (80.00%) were infected with subtype A and one subject (20.00%) was infected with subtype C. Subtype C2 and C3 and all known subtype A, except A5, were found in classic KS. In AIDS-KS, subtype A1, A2 and C3 were identified (Table 2). In this study, subtype A/C ratios in Classic KS and AIDS-associated KS were not significantly different (Fisher’s exact test); Subtype A/C ratios in Uygur patients and Kazakh patients were also not significant different (Fisher’s exact test, Table 3). By using neighbor-joining analysis with Phylip, we saw a similar topology (see Supplementary File).

Table 2. KSHV K1 genotypes between classic KS and AIDS KS.
Table 2. KSHV K1 genotypes between classic KS and AIDS KS.
KS SubtypeK1 Subtype *
Classic KS
A (19)A12
A211
A34
A42
C (4)C22
C32
AIDS-associated KS
A (4)A11
A23
C (1)C31

* KSHV subtype A/C ratios of classic and AIDS-KS were not significantly different (Fisher’s exact test).

Table 3. KSHV K1 genotypes in different ethnic patients.
Table 3. KSHV K1 genotypes in different ethnic patients.
KSHV IsolatesGenBank Accession NumbersEthnicitySubtypes
XUAR1KM582680UygurA2
XUAR2KM582681KazakhA3
XUAR3KM582682UygurA3
XUAR4KM582683UygurA1
XUAR5KM582684UygurA2
XUAR 6KM582685UygurA3
XUAR7KM582687UygurC3
XUAR8KM582688KazakhA4
XUAR9KM582689UygurC3
XUAR10KM582690UygurC2
XUAR11KM582691KazakhC2
XUAR12KM582692KazakhA1
XUAR13KM582693UygurA2
XUAR14KM582694HuiA2
XUAR15KM582695UygurA2
XUAR16KM582696HanA4
XUAR17KM582697UygurA2
XUAR18KM582698KazakhA3
XUAR19KM582699UygurA2
XUAR20KM582700KazakhA2
XUAR21KM582701KazakhA2
XUAR22KM582702UygurA2
XUAR23KM582703KazakhA2
XUAR24KM582704UygurC3
XUAR25KM582705UygurA2
XUAR26KM582706UygurA2
XUAR27KM582707UygurA1
XUAR28KM582708UygurC3

KSHV subtype A/C ratios in different ethnic patients were not significantly different (Fisher’s exact test).

Figure 1. Phylogenetic tree of KSHV ORF-K1 DNA sequences constructed by MEGA (version 4.0.2) using the neighbor-joining algorithm. Relationships of KSHV isolates in present study and isolates in the literature are shown. KSHV isolates in present study were named by XUAR. XUAR1-XUAR23 were isolated from classic KS tissues, XUAR24-XUAR28 were isolated from AIDS-KS tissues. Ema7, US-114, BCBL-B, IT-268, KE229, XJ6, XJ20, XJ-27, XJ-30, AF170531, AF178810, AF220292, FJ884616, UG-65, UG-85, MP10, TKS10, ZKS3, and Sio1 were downloaded from NCBI.
Figure 1. Phylogenetic tree of KSHV ORF-K1 DNA sequences constructed by MEGA (version 4.0.2) using the neighbor-joining algorithm. Relationships of KSHV isolates in present study and isolates in the literature are shown. KSHV isolates in present study were named by XUAR. XUAR1-XUAR23 were isolated from classic KS tissues, XUAR24-XUAR28 were isolated from AIDS-KS tissues. Ema7, US-114, BCBL-B, IT-268, KE229, XJ6, XJ20, XJ-27, XJ-30, AF170531, AF178810, AF220292, FJ884616, UG-65, UG-85, MP10, TKS10, ZKS3, and Sio1 were downloaded from NCBI.
Viruses 06 04800 g001 1024

4. Discussion

Traditionally, herpesviruses are considered to be co-evolved with their hosts throughout vertebrate evolution. KSHV is an ancient human virus and spread together with its migrating human hosts [21]. Many studies have found seven subtypes of KSHV (A, B, C, D, E, F and Z) and identified that KSHV subtypes have close associations with the geographic and ethnic background of patients. Subtypes A and C have the largest prevalence area, including Africa, Europe, Middle East, Asia [12,22], America and Australia. Subtype D has been reported from the Pacific Islands, like Japan [12,16], Chinese Taiwan [23], and Australia. Subtype B is found from patients of African origin [24], only one subtype B isolates separated from a Mexican female AIDS patient in Miami [14]. Subtype E was only found in Amerindians [15,25]. Subtype Z has been found in Zambian [17]. Subtype F is rare and was only found in Africa recently [13].

In China, KS cases are rare, only reported in Xinjiang Region [20] and Taiwan Island [26]. However, KSHV subtypes in these regions are quite different from each other. Previous research and this study have found the KSHV subtypes in Xinjiang region are subtypes A and C, while in Taiwan it is subtypes C and D [23]. This difference may have geographic reasons. Taiwan is an island in the Pacific, while Xinjiang located in central Asia. Xinjiang is home to a number of different ethnic groups, including the Uyghur, Han, Kazakh, Hui, Kyrgyz, Xibo and Mongolians. Historically, the population in Xinjiang consisted of various nomadic tribes, like Yuezhi, Xiongnu, and Wusun. Well-preserved Tarim mummies with Caucasoid features, often with reddish or blond hair, which dated from 1800 BCE to 200 CE, which were different from the Han Chinese, have been found in Xinjiang area. Today the minorities, including Uyghur, Kazakh and Hui, still have significant difference from the Han. The epidemiology study has found that the seroprevalence of KSHV in the general population was higher than the other provinces in China, and the minorities (Uyghur, Kazakh, Hui, and Xibo) have higher KSHV-seropositive ratio than the Han [18]. Previous researches have suggested that KSHV has been introduced to Xinjiang Region along the Silk Road. The Silk Road was a path for cultural, commercial and technological exchange between Ancient China, India, the Persian Empire and Mediterranean countries for nearly 3000 years. The Silk Road was extended to the center of China, and Xinjiang was a section of the Silk Road. In our study, two subtypes of KSHV were identified, 23 of them belonged to subtype A, while five of them were subtype C. More genotype A was found than genotype C, both in Classical KS and AIDS KS. No significant difference was found in the predominance of different genotype between Classical KS and AIDS KS.

Co-migration of viruses with the human population is common. KSHV subtypes A and C are predominant in the Mediterranean, Middle Eastern and Asian regions [12,22], which were parts of the ancient Great Silk Road that went through the Xinjiang region. KSHV subtype C has been found in Xinjiang in 2001 [19]. KSHV subtype A has also been found in Xinjiang by our study in 2009 [18]. In this study, both KSHV subtype A and C were identified. Thus, it is tempting to speculate that KSHV might have been spread along the Silk Road with the human population.

Classic KS was only found in Xinjiang Minority, but not often seen in Han population. More epidemiologic study should be done to investigate the risk factors, including environmental and human genetic factors.

Supplementary Files

Supplementary File 1

Acknowledgments

This work was supported by National Science Foundation of China (Grant No. 81271837) and Natural Science Foundation Key project of Anhui Education Department (KJ2012A161).

Author Contributions

XO and YZ carried out the experiment and drafted the manuscript. BF, XW, WC and YF participated in design and coordination of study, data and sample collection. ML and LW conceived study, provided guidance to all aspects of study, and performed quality assessment of data, data analysis, data preparation, and drafted manuscript. All authors read and approved final manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References and Notes

  1. Kaposi, M. Idiopathisches multiples pigmentsarkom der haut. Arch. Dermatol. Syph. 1872, 4, 265–273. [Google Scholar] [CrossRef]
  2. Beral, V.; Peterman, T.A.; Berkelman, R.L.; Jaffe, H.W. Kaposi’s sarcoma among persons with aids: A sexually transmitted infection? Lancet 1990, 335, 123–128. [Google Scholar] [CrossRef] [PubMed]
  3. Antman, K.; Chang, Y. Kaposi’s sarcoma. N. Engl. J. Med. 2000, 342, 1027–1038. [Google Scholar] [CrossRef] [PubMed]
  4. Friedman-Kien, A.E.; Saltzman, B.R. Clinical manifestations of classical, endemic african, and epidemic aids-associated kaposi’s sarcoma. J. Am. Acad. Dermatol. 1990, 22, 1237–1250. [Google Scholar] [CrossRef]
  5. Iscovich, J.; Boffetta, P.; Winkelmann, R.; Brennan, P.; Azizi, E. Classic kaposi’s sarcoma in jews living in israel, 1961–1989: A population-based incidence study. Aids 1998, 12, 2067–2072. [Google Scholar] [PubMed]
  6. Guo, W.X.; Antakly, T. Aids-related kaposi’s sarcoma: Evidence for direct stimulatory effect of glucocorticoid on cell proliferation. Am. J. Pathol. 1995, 146, 727–734. [Google Scholar] [PubMed]
  7. Fatahzadeh, M. Kaposi sarcoma: Review and medical management update. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2012, 113, 2–16. [Google Scholar] [CrossRef] [PubMed]
  8. Chang, Y.; Cesarman, E.; Pessin, M.S.; Lee, F.; Culpepper, J.; Knowles, D.M.; Moore, P.S. Identification of herpesvirus-like DNA sequences in aids-associated kaposi’s sarcoma. Science 1994, 266, 1865–1869. [Google Scholar] [CrossRef] [PubMed]
  9. Cesarman, E.; Chang, Y.; Moore, P.S.; Said, J.W.; Knowles, D.M. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in aids-related body-cavity-based lymphomas. N. Engl. J. Med. 1995, 332, 1186–1191. [Google Scholar] [CrossRef] [PubMed]
  10. Soulier, J.; Grollet, L.; Oksenhendler, E.; Cacoub, P.; Cazals-Hatem, D.; Babinet, P.; d’Agay, M.F.; Clauvel, J.P.; Raphael, M.; Degos, L.; et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric castleman’s disease. Blood 1995, 86, 1276–1280. [Google Scholar] [PubMed]
  11. Russo, J.J.; Bohenzky, R.A.; Chien, M.C.; Chen, J.; Yan, M.; Maddalena, D.; Parry, J.P.; Peruzzi, D.; Edelman, I.S.; Chang, Y.; et al. Nucleotide sequence of the kaposi sarcoma-associated herpesvirus (hhv8). Proc. Natl. Acad. Sci. USA 1996, 93, 14862–14867. [Google Scholar] [CrossRef] [PubMed]
  12. Kanno, T.; Sato, Y.; Nakamura, T.; Sakamoto, K.; Sata, T.; Katano, H. Genotypic and clinicopathological characterization of kaposi’s sarcoma-associated herpesvirus infection in japan. J. Med. Virol. 2010, 82, 400–406. [Google Scholar] [CrossRef] [PubMed]
  13. Kajumbula, H.; Wallace, R.G.; Zong, J.C.; Hokello, J.; Sussman, N.; Simms, S.; Rockwell, R.F.; Pozos, R.; Hayward, G.S.; Boto, W. Ugandan kaposi’s sarcoma-associated herpesvirus phylogeny: Evidence for cross-ethnic transmission of viral subtypes. Intervirology 2006, 49, 133–143. [Google Scholar] [CrossRef] [PubMed]
  14. Hayward, G.S.; Zong, J.C. Modern evolutionary history of the human kshv genome. Curr. Top. Microbiol. Immunol. 2007, 312, 1–42. [Google Scholar] [PubMed]
  15. Biggar, R.J.; Whitby, D.; Marshall, V.; Linhares, A.C.; Black, F. Human herpesvirus 8 in brazilian amerindians: A hyperendemic population with a new subtype. J. Infect. Dis. 2000, 181, 1562–1568. [Google Scholar] [CrossRef] [PubMed]
  16. Meng, Y.X.; Sata, T.; Stamey, F.R.; Voevodin, A.; Katano, H.; Koizumi, H.; Deleon, M.; de Cristofano, M.A.; Galimberti, R.; Pellett, P.E. Molecular characterization of strains of human herpesvirus 8 from japan, argentina and kuwait. J. Gen. Virol. 2001, 82, 499–506. [Google Scholar] [PubMed]
  17. Kasolo, F.C.; Monze, M.; Obel, N.; Anderson, R.A.; French, C.; Gompels, U.A. Sequence analyses of human herpesvirus-8 strains from both african human immunodeficiency virus-negative and -positive childhood endemic kaposi’s sarcoma show a close relationship with strains identified in febrile children and high variation in the k1 glycoprotein. J. Gen. Virol. 1998, 79, 3055–3065. [Google Scholar] [PubMed]
  18. Fu, B.; Sun, F.; Li, B.; Yang, L.; Zeng, Y.; Sun, X.; Xu, F.; Rayner, S.; Guadalupe, M.; Gao, S.J.; et al. Seroprevalence of kaposi’s sarcoma-associated herpesvirus and risk factors in xinjiang, china. J. Med. Virol. 2009, 81, 1422–1431. [Google Scholar] [CrossRef] [PubMed]
  19. Dilnur, P.; Katano, H.; Wang, Z.H.; Osakabe, Y.; Kudo, M.; Sata, T.; Ebihara, Y. Classic type of kaposi’s sarcoma and human herpesvirus 8 infection in xinjiang, china. Pathol. Int. 2001, 51, 845–852. [Google Scholar] [CrossRef] [PubMed]
  20. Zhang, D.Z.; Pu, X.M.; Wu, W.D.; Jin, Y.; Juhear, M.; Wu, X.J. Genotypic analysis on the orf-k1 gene of human herpesvirus 8 from patients with kaposi’s sarcoma in xinjiang, china. J. Genet. Genomics 2008, 35, 657–663. [Google Scholar] [CrossRef] [PubMed]
  21. Hayward, G.S. Kshv strains: The origins and global spread of the virus. Semin. Cancer Biol. 1999, 9, 187–199. [Google Scholar] [CrossRef] [PubMed]
  22. Cook, P.M.; Whitby, D.; Calabro, M.L.; Luppi, M.; Kakoola, D.N.; Hjalgrim, H.; Ariyoshi, K.; Ensoli, B.; Davison, A.J.; Schulz, T.F. Variability and evolution of kaposi’s sarcoma-associated herpesvirus in europe and africa. International collaborative group. Aids 1999, 13, 1165–1176. [Google Scholar] [PubMed]
  23. Zong, J.C.; Ciufo, D.M.; Alcendor, D.J.; Wan, X.; Nicholas, J.; Browning, P.J.; Rady, P.L.; Tyring, S.K.; Orenstein, J.M.; Rabkin, C.S.; et al. High-level variability in the orf-k1 membrane protein gene at the left end of the kaposi’s sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J. Virol. 1999, 73, 4156–4170. [Google Scholar] [PubMed]
  24. White, T.; Hagen, M.; Gudza, I.; White, I.E.; Ndemera, B.; Gwanzura, L.; Borok, M.; Campbell, T.B. Genetic diversity of the kaposi’s sarcoma herpesvirus k1 protein in aids-ks in zimbabwe. J. Clin. Virol. 2008, 42, 165–171. [Google Scholar] [PubMed]
  25. Whitby, D.; Marshall, V.A.; Bagni, R.K.; Wang, C.D.; Gamache, C.J.; Guzman, J.R.; Kron, M.; Ebbesen, P.; Biggar, R.J. Genotypic characterization of kaposi’s sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. J. Gen. Virol. 2004, 85, 155–163. [Google Scholar] [CrossRef] [PubMed]
  26. Su, I.J.; Hsu, Y.S.; Chang, Y.C.; Wang, I.W. Herpesvirus-like DNA sequence in kaposi’s sarcoma from aids and non-aids patients in taiwan. Lancet 1995, 345, 722–723. [Google Scholar] [CrossRef] [PubMed]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top